Paul Hahn, MD, PhD

Articles by Paul Hahn, MD, PhD

Paul Hahn, MD, PhD, shares insights on pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy

ByPaul Hahn, MD, PhD,Sydney M Crago, Editor, Modern Retina,David Hutton, Managing Editor, Ophthalmology Times

August 7th 2023

Paul Hahn, MD, PhD, shared insights on research comparing the relative efficacy of pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy presented at the 2023 ASRS annual meeting.

Paul Hahn, MD, PhD

Articles by Paul Hahn, MD, PhD

Paul Hahn, MD, PhD, shares insights on pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy

Latest Updated Articles

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Seeing the signs: The subtle clues of human trafficking as seen in the clinic

AAOpt 2025: Early response to treatment with perfluorohexyloctane ophthalmic solution for dry eye disease

AAOpt 2025: Thomas Wong, OD, discusses the role of optometric telehealth